Y Intercept Hong Kong Ltd Sells 13,143 Shares of Select Medical Holdings Co. (NYSE:SEM)

Y Intercept Hong Kong Ltd lessened its position in Select Medical Holdings Co. (NYSE:SEM) by 58.2% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 9,425 shares of the health services provider’s stock after selling 13,143 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Select Medical were worth $329,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quarry LP bought a new stake in Select Medical during the 3rd quarter valued at approximately $30,000. Transcendent Capital Group LLC bought a new stake in shares of Select Medical in the second quarter valued at approximately $35,000. Canada Pension Plan Investment Board acquired a new stake in shares of Select Medical in the second quarter worth $39,000. DekaBank Deutsche Girozentrale bought a new position in Select Medical during the second quarter worth $60,000. Finally, GAMMA Investing LLC raised its stake in Select Medical by 16.6% during the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock valued at $81,000 after purchasing an additional 330 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on SEM shares. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a report on Tuesday, December 3rd. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Bank of America assumed coverage on Select Medical in a research report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price objective for the company. Finally, Royal Bank of Canada boosted their price objective on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th.

Insider Transactions at Select Medical

In other news, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the sale, the director now directly owns 22,000 shares of the company’s stock, valued at $463,980. This represents a 59.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at $605,602.20. This trade represents a 14.12 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 19.14% of the company’s stock.

Select Medical Stock Performance

Shares of NYSE:SEM opened at $19.12 on Wednesday. The stock has a market capitalization of $2.48 billion, a price-to-earnings ratio of 8.93, a price-to-earnings-growth ratio of 0.39 and a beta of 1.43. The business’s fifty day moving average price is $30.97 and its two-hundred day moving average price is $33.67. Select Medical Holdings Co. has a fifty-two week low of $19.05 and a fifty-two week high of $40.98. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the company posted $0.46 EPS. As a group, analysts predict that Select Medical Holdings Co. will post 1.97 EPS for the current fiscal year.

Select Medical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were given a $0.125 dividend. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 annualized dividend and a yield of 2.62%. Select Medical’s payout ratio is 23.36%.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.